ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma.

Front Genet · 2022 · PMC8960381 · PMID 35360875

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

It has been reported that ASF1B, rather than ASF1A, is critical for proliferation and has highly significant prognostic value in breast cancer and cervical cancer ( Corpet et al., 2011 ; Han et al., 2018 ; Jiangqiao et al., 2019 ; Liu et al., 2020 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.